Announced Thu, 25 Jun · 15:20 IST
Trading window closed from July 1, 2026 till Q1 results
Compliance View source PDF
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.7%1-day move
₹1528.10
prior close
₹1555.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0———+0.7+3.0+1.4+2.3+5.8+3.6+0.5+1.5——
Up moveDown movePending
AI summary
Aurobindo Pharma has closed the trading window for dealing in its securities from July 1, 2026 until 48 hours after the declaration of unaudited financial results for Q1 ending June 30, 2026. The closure applies to all designated persons including promoters, directors, key managerial personnel, employees, connected persons and their immediate relatives. The board meeting date to approve the Q1 results will be announced later.
Likely market impact
Routine SEBI compliance announcement ahead of quarterly results. No direct impact on retail shareholders.